Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-10-18 00:00:00 ET · period of report 2023-10-17 · accession 0001628280-23-034571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-18 | 2023-10-17 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | -1.75M | 168.5K | -91% | $0 | |
| MI | 2023-10-18 | 2023-10-17 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | +1.75M | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-17 | J | D | 1,750,000 | $0.00 | 168,489 | D See footnote | — | — | (F2) The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. |
| 2 | Common | Common Stock | 2023-10-17 | J | A | 1,750,000 | $0.00 | 1,750,000 | I See footnote | — | — | (F3) The shares are held by the spouse of the reporting person. |
| 3 | Common | Common Stock | 2023-10-17 | J | A | 1,750,000 | $0.00 | 1,750,000 | I | — | — | |
| 4 | Common | Common Stock | 2023-10-17 | J | D | 1,750,000 | $0.00 | 0 | I See footnote | — | — | (F4) The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. |